Page 301 - Read Online
P. 301

Robinson et al. J Cancer Metastasis Treat 2019;5:39                 Journal of Cancer
               DOI: 10.20517/2394-4722.2019.15                           Metastasis and Treatment




               Review                                                                        Open Access


               Stem cells, immortality, and the evolution of
               metastatic properties in breast cancer: telomere

               maintenance mechanisms and metastatic evolution


               Nathaniel J. Robinson , Derek J. Taylor , William P. Schiemann 3
                                                2
                                  1
               1 Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
               2 Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
               3 Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.

               Correspondence to: Dr. William P. Schiemann, Case Comprehensive Cancer Center, Case Western Reserve University, Wolstein
               Research Building, Room 2131, 2103 Cornell Road Cleveland, OH 44106, USA. E-mail: wps20@case.edu

               How to cite this article:  Robinson  NJ,  Taylor  DJ,  Schiemann  WP.  Stem  cells,  immortality,  and  the  evolution  of  metastatic
               properties in breast cancer: telomere maintenance mechanisms and metastatic evolution. J Cancer Metastasis Treat 2019;5:39.
               http://dx.doi.org/10.20517/2394-4722.2019.15

               Received: 8 Feb 2019    First Decision: 13 Mar 2019    Revised: 2 Apr 2019    Accepted: 8 Apr 2019    Published: 6 May 2019

               Science Editor: Ya-Guang Xi    Copy Editor: Cai-Hong Wang    Production Editor: Huan-Liang Wu


               Abstract
               Breast cancer is the most significant cause of cancer-related death in women around the world. The vast majority of
               breast cancer-associated mortality stems from metastasis, which remains an incurable disease state. Metastasis results
               from evolution of clones that possess the insidious properties required for dissemination and colonization of distant
               organs. These clonal populations are descended from breast cancer stem cells (CSCs), which are also responsible for
               their prolonged maintenance and continued evolution. Telomeres impose a lifespan on cells that can be extended when
               they are actively elongated, as occurs in CSCs. Thus, changes in telomere structure serve to promote the survival of
               CSCs and subsequent metastatic evolution. The selection of telomere maintenance mechanism (TMM) has important
               consequences not only for CSC survival and evolution, but also for their coordination of various signaling pathways
               that choreograph the metastatic cascade. Targeting the telomere maintenance machinery may therefore provide a
               boon to the treatment of metastatic breast cancer. Here we review the two major TMMs and the roles they play in the
               development of stem and metastatic breast cancer cells. We also highlight current and future approaches to targeting
               these mechanisms in clinical settings to alleviate metastatic breast cancers.


               Keywords: Breast cancer, cancer evolution, cancer stem cells, metastasis, telomerase




                           © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                  www.jcmtjournal.com
   296   297   298   299   300   301   302   303   304   305   306